Clinical Trials
3 trialsNCT07395258 2026-06-04
A Study to Test Different Doses of BI 3923948 Alone and in Combination With an Anti-PD-1 Antibody in People With Different Types of Advanced Cancer (Solid Tumors)
Boehringer Ingelheim
Phase 1 Suspended
NCT05155332 2026-05-20
A Study to Test Different Doses of BI 1831169 Alone and in Combination With an Anti-PD-1 Antibody in People With Different Types of Advanced Cancer (Solid Tumors)
Boehringer Ingelheim
Phase 1 Suspended
NCT00591682 2008-03-26
MSX-122 Administered Orally in Patients With Refractory Metastatic or Locally Advanced Solid Tumors
Metastatix, Inc.
Phase 1 Suspended